SCHEMBL9435566

SCHEMBL9435566

O=C1NCCCC1C(=O)c1cccnc1.[LiH]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 2/20 0.44
ALDH1A1 P00352 5/20 0.44
GAA P10253 3/20 0.44
APP P05067 1/20 0.44
HCAR3 P49019 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
GFER P55789 1/20 0.43
TSHR P16473 1/20 0.43
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
SARM1 Q6SZW1 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT6 Q8N6T7 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239882 0.99 L3MBTL1 (0.50) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL29365856 0.82 MCL1 (0.56) L3MBTL1KDM4EMEN1KMT2APOLB
SCHEMBL10354365 0.78 MCL1 (0.59) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL1720721 0.77 MCL1 (0.67) L3MBTL1KDM4EMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL29516338 0.76 MCL1 (0.57) L3MBTL1KDM4EMEN1KMT2APOLB
SCHEMBL9016165 0.75 KDM4E (0.50) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL9016167 0.74 KDM4E (0.49) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL7241178 0.74 CHRNB2 (0.48) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL9016170 0.74 MEN1 (0.49) L3MBTL1KDM4EMAPTMEN1KMT2A
SCHEMBL8245353 0.73 SLC18A3 (0.56) L3MBTL1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0573568-A4 USE OF NICOTINIC ANALOGS FOR TREATMENT OF DEGENERATIVE DISEASES OF THE NERVOUS SYSTEM UNIV FLORIDA (US) 1994-09-21 EP claimed
EP-0573568-A1 USE OF NICOTINIC ANALOGS FOR TREATMENT OF DEGENERATIVE DISEASES OF THE NERVOUS SYSTEM UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 1993-12-15 EP claimed
WO-1992015306-A1 USE OF NICOTINIC ANALOGS FOR TREATMENT OF DEGENERATIVE DISEASES OF THE NERVOUS SYSTEM UNIVERSITY OF FLORIDA (US) 1992-09-17 WO claimed
US-9567315-B1 Method for synthesis of 4-OH substituted anabaseine derivative Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. (TW) 2017-02-14 US disclosed